Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts
- 1 November 1999
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 13 (14) , 1991-2001
- https://doi.org/10.1096/fasebj.13.14.1991
Abstract
The histone deacetylase inhibitor and potential anti-cancer drug sodium butyrate is a general inducer of growth arrest, differentiation, and in certain cell types, apoptosis. In human CCRF-CEM, acute T lymphoblastic leukemia cells, butyrate, and other histone deacetylase inhibitors caused G2/M cell cycle arrest as well as apoptotic cell death. Forced G0/G1 arrest by tetracycline-regulated expression of transgenic p16/INK4A protected the cells from butyrate-induced cell death without affecting the extent of histone hyperacetylation, suggesting that the latter may be necessary, but not sufficient, for cell death induction. Nuclear apoptosis, but not G2/M arrest, was delayed but not prevented by the tripeptide broad-range caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp·fluoromethylketone (zVAD) and, to a lesser extent, by the tetrapeptide ‘effector caspase’ inhibitors benzyloxycarbonyl-Asp-Glu-Val-Asp·fluoromethylketone (DEVD) and benzyloxycarbonyl-Val-Glu-Ile-Asp·fluoromethyl-ketone (VEID); however, the viral protein inhibitor of ‘inducer caspases’, crmA, had no effect. Bcl-2 overexpression partially protected stably transfected CCRF-CEM sublines from butyrate-induced apoptosis, but showed no effect on butyrate-induced growth inhibition, further distinguishing these two butyrate effects. c-myc, constitutively expressed in CCRF-CEM cells, was down-regulated by butyrate, but this was not causative for cell death. On the contrary, tetracycline-induced transgenic c-myc sensitized stably transfected CCRF-CEM derivatives to butyrate-induced cell death.—Bernhard, D., Ausserlechner, M. J., Tonko, M., Löffler, M., Hartmann, B. L., Csordas, A., Kofler, R. Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts.Keywords
Funding Information
- Austrian Science Fund (SFB‐F204, P‐11946‐Med)
- Oesterreichische Nationalbank (ÖNB‐6156)
- Universität Innsbruck
This publication has 42 references indexed in Scilit:
- c-Myc does not prevent glucocorticoid-induced apoptosis of human leukemic lymphoblastsOncogene, 1999
- Bcl-2 interferes with the execution phase, but not upstream events, in glucocorticoid-induced leukemia apoptosisOncogene, 1999
- Sodium butyrate induces apoptosis and accumulation of ubiquitinated proteins in human breast carcinoma cellsCell Death & Differentiation, 1998
- Modulation of Heat-Shock Protein 70 (HSP70) Gene Expression by Sodium Butyrate in U-937 Promonocytic Cells: Relationships with Differentiation and ApoptosisExperimental Cell Research, 1997
- Butyrate modulates DNA-damage-induced p53 response by induction of p53-independent differentiation and apoptosisOncogene, 1997
- Caspase-4 and caspase-5, members of the ICE/CED-3 family of cysteine proteases, are CrmA-inhibitable proteasesCell Death & Differentiation, 1997
- What's Up and Down with Histone Deacetylation and Transcription?Cell, 1997
- Targeting Chromatin Disruption: Transcription Regulators that Acetylate HistonesCell, 1996
- Clinical pharmacology of sodium butyrate in patients with acute leukemiaEuropean Journal of Cancer and Clinical Oncology, 1987
- Cloning and sequencing of a deoxyribonucleic acid copy of glyceraldehyde 3-phosphate dehydrogenase messenger ribonucleic acid isolated from chicken muscleBiochemistry, 1983